SMAD2 and breast carcinoma: Furthermore, Rd treatment specifically increased the luciferase reporter activity of Smad2 3′-UTR containing miR-18a seed region, supporting the implication of miR-18a-mediated Smad2 regulation in the anti-metastatic effect of Rd in 4T1 mammary carcinoma cells.